Detalles de la búsqueda
1.
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group.
Ann Oncol
; 28(4): 843-848, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28031174
2.
A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor.
Ann Oncol
; 29(2): 514-515, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29088313
3.
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network.
Eur J Cancer
; 117: 121-130, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31279304
4.
[Association of type 1 neurofibromatosis and primary hyperparathyroidism]. / Association neurofibromatose de type I et hyperparathyroïdie primitive.
Presse Med
; 31(34): 1604-5, 2002 Oct 19.
Artículo
en Francés
| MEDLINE | ID: mdl-12426977
5.
Addition of plerixafor to G-CSF is useful to achieve efficient collection even in very poor mobilizers: hope for patients with diminished hematopoietic function.
Bone Marrow Transplant
; 52(7): 1049-1050, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28530669
6.
The choice of in-hospital or home administration for plerixafor injection to poor mobilizers has no adverse consequence on subsequent hematopoietic stem cell harvest.
Bone Marrow Transplant
; 52(8): 1212-1214, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28581475
7.
[Hematopoietic stem cells mobilization: state of the art in 2011 and perspectives]. / Mobilisation des cellules souches hématopoïétiques: état de l'art en 2011 et perspectives.
Transfus Clin Biol
; 18(5-6): 503-15, 2011 Dec.
Artículo
en Francés
| MEDLINE | ID: mdl-22019608
Resultados
1 -
7
de 7
1
Próxima >
>>